Published in Ann Intern Med on December 01, 1975
In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Antimicrob Agents Chemother (1976) 1.57
Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections. Antimicrob Agents Chemother (1977) 1.30
Netilmicin: clinical efficacy, tolerance, and toxicity. Antimicrob Agents Chemother (1978) 1.29
Ototoxicity of amikacin. Antimicrob Agents Chemother (1976) 1.25
Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods. Br Med J (1976) 1.20
Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae. Antimicrob Agents Chemother (1976) 1.09
Bronchial secretion levels of amikacin. Antimicrob Agents Chemother (1979) 1.08
In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens. Antimicrob Agents Chemother (1976) 1.00
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. Antimicrob Agents Chemother (1980) 0.97
Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients. Antimicrob Agents Chemother (1977) 0.95
Gentamicin use and Pseudomonas and Serratia resistance: effect of a surgical prophylaxis regimen. Antimicrob Agents Chemother (1978) 0.90
Phenotypic factors correlated with the absence of virulence among gentamicin-resistant Pseudomonas aeruginosa strains. J Clin Microbiol (1984) 0.87
Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram. Antimicrob Agents Chemother (1988) 0.85
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents. Antimicrob Agents Chemother (1982) 0.83
Cerebrospinal fluid penetration of amikacin. Antimicrob Agents Chemother (1978) 0.82
Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function. Ann Surg (1982) 0.77
Therapeutic experience with netilmicin. Can Med Assoc J (1978) 0.75
Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54
Rapid diagnosis of bacteremia. Appl Microbiol (1969) 11.82
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med (1991) 7.83
Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol (1971) 6.99
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline. Appl Microbiol (1972) 6.17
Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems. Appl Microbiol (1972) 6.04
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Rapid diagnosis of bacteremia with quantitative differential-membrane filtration culture. JAMA (1966) 5.66
Practical aerobic membrane filtration blood culture technique: clinical blood culture trial. J Clin Microbiol (1975) 4.80
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis (1972) 4.62
Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr (1974) 4.58
Legionnaires' disease: clinical features of 24 cases. Ann Intern Med (1978) 4.30
Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis (1975) 4.16
Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis (1980) 3.95
Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens. J Clin Microbiol (1979) 3.86
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80
Evaluation of polyanethol sulfonate (liquoid) in blood cultures. Antimicrob Agents Chemother (Bethesda) (1967) 3.80
Comparison of three procedures for biochemical testing of anaerobic bacteria. J Clin Microbiol (1975) 3.75
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med (1972) 3.62
Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrob Agents Chemother (1973) 3.47
A critical review of the systolic time intervals. Circulation (1977) 3.34
Comparison of methods for isolation of anaerobic bacteria from clinical specimens. Appl Microbiol (1973) 3.30
Anaerobic pleuropulmonary infections. Medicine (Baltimore) (1972) 3.30
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14
Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med (1972) 3.05
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) (1980) 2.81
Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. J Infect Dis (1980) 2.76
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1981) 2.71
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Purification and characterization of Clostridium difficile toxin. Infect Immun (1979) 2.71
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
Effect of a partially chemically defined diet on normal human fecal flora. Am J Clin Nutr (1972) 2.62
Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol (1971) 2.60
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52
Comparison of selective media for isolation of presumptive group D streptococci from human feces. Appl Microbiol (1971) 2.52
Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol (2000) 2.50
Susceptibility of Legionella pneumophila to twenty antimicrobial agents. Antimicrob Agents Chemother (1980) 2.49
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Anaerobic infections of the lung and pleural space. Am Rev Respir Dis (1974) 2.46
Legionnaires' disease: unusual clinical and laboratory features. Ann Intern Med (1980) 2.46
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Combined screw-cap and rubber-stopper closure for Hungate tubes (pre-reduced anaerobically sterilized roll tubes and liquid media). Appl Microbiol (1969) 2.44
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics. Antimicrob Agents Chemother (1972) 2.42
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species. Rev Infect Dis (1981) 2.38
Legionella infections: a review of five years of research. Rev Infect Dis (1983) 2.30
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. Rev Infect Dis (1981) 2.27
Cephalothin in serious bacterial infection. Ann Intern Med (1966) 2.25
Antimicrobial resistance in Bacteroides. J Antimicrob Chemother (1987) 2.23
Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteria. J Clin Microbiol (1981) 2.22
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Isolation of a new serotype of legionnaires' disease bacterium. Lancet (1978) 2.21
Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother (1975) 2.21
Practical aerobic membrane filtration blood culture technique: development of procedure. J Clin Microbiol (1975) 2.20
Phycomycosis complicating leukemia and lymphoma. Ann Intern Med (1972) 2.17
Therapy for infections due to anaerobic bacteria: an overview. J Infect Dis (1977) 2.14
Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. Antimicrob Agents Chemother (1976) 2.12
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group. Ann Intern Med (1994) 2.12
Joint infection by anaerobic bacteria: a case report and review of the literature. Arthritis Rheum (1969) 2.09
Uncommonly encountered, motile, anaerobic gram-negative bacilli associated with infection. Rev Infect Dis (1988) 2.09
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital. Lancet (1976) 2.07
The bacteriology of gangrenous and perforated appendicitis--revisited. Ann Surg (1990) 2.05
A microbiological comparison between acute and complicated appendicitis. Clin Infect Dis (1992) 2.02
Bacteriology of empyema. Lancet (1974) 2.00
Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. J Gen Microbiol (1989) 1.98
Isolation of Legionella pneumophila from blood. Lancet (1979) 1.97
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90
Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis (1986) 1.88
Infections due to anaerobes. Med Times (1968) 1.86
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. Gastroenterology (1980) 1.84
ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. Antimicrob Agents Chemother (1978) 1.81
A miniature anaerobic jar for tissue transport or for cultivation of anaerobes. Am J Clin Pathol (1970) 1.79
Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem (2001) 1.77
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother (1985) 1.77
Diarrhea and colitis associated with antimicrobial therapy in man and animals. Am J Clin Nutr (1979) 1.76
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob Agents Chemother (1996) 1.76
Infectious complications of neoplastic disease. Med Clin North Am (1971) 1.75
Legionnaires' disease in renal-transplant recipients. Lancet (1978) 1.75